Clinical Trials Directory

Trials / Unknown

UnknownNCT03071198

Clinical Effect of Neoadjuvant Hierarchical Treatment Based on Chemotherapy

Clinical Effect of Neoadjuvant Hierarchical Treatment Based on Chemotherapy for T3-4N0-2M0 Middle and Lower Rectal Cancer

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
1 (estimated)
Sponsor
Harbin Medical University · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Accepted

Summary

Clinical effect of neoadjuvant hierarchical treatment based on chemotherapy for T3-4N0-2M0 middle and lower rectal cancer

Detailed description

By setting 3-Year disease-free survival (DFS) as main objective, the treatment strategy will be optimizing as neoadjuvant chemotherapy alone and chemo-radio-chemo sequential treatment.

Conditions

Interventions

TypeNameDescription
PROCEDURETME1. Find the hypogastric nerve trunk in front of sacral promontory and protect it,be careful to use electrocautery hemostasis biased toward the side of rectal when handle lateral ligament of rectum and middle rectal artery and avoid to damage the pelvic plexus. 2. At least a 2-cm margin to the lower edge of the tumor is adequate for distal bowel resection. Resect 5cm length distal rectal or all of the mesorectum.Check the integrity of the mesorectum in postoperative routine examination. Double stapling method is used for all low anastomosis operations.
RADIATIONConcurrent chemo-radiotherapyThree-dimensional conformal radiotherapy as following: CTV 44Gy/22 times+GTV1 6Gy/3 times(2Gy/time/day,5 days a week,totally 5 weeks),if rectal tumors do not regress obviously, additional GTV2 is necessary, 5.4Gy/3 times (1.8Gy/time/day). At the same time, Capecitabine (850mg/m2, two times every day) will be taken on radiotherapy day
DRUGneoadjuvant CTCAPEOX protocol:Oxaliplatin 130mg/m2 ivgtt 2-6h dl;(Capecitabine 1000mg/m2 2 times a day lasts for 14 days Repeat every 3 weeks
DRUGadjuvant CTCAPEOX protocol:Oxaliplatin 130mg/m2 ivgtt 2-6h dl;(Capecitabine 1000mg/m2 2 times a day lasts for 14 days Repeat every 3 weeks

Timeline

Start date
2017-03-01
Primary completion
2018-09-30
Completion
2021-09-30
First posted
2017-03-06
Last updated
2017-03-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03071198. Inclusion in this directory is not an endorsement.